Interaction policosanol-warfarin on bleeding time and thrombosis in rats

Pharmacological Research

Volumn 38, Issue 2, 1998, Pages 89-91

  Carbajal, D ^a   Arruzazabala, M L ^a   Valdes S ^a   Mas R ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

Bleeding time; Policosanol; Thrombosis; Warfarin

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; POLICOSANOL; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VEIN THROMBOSIS;

EID: 0032145343     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0324     Document Type: Article

References (18)

1. 1. Arruzazabala ML, Carbajal D, Más R, Molina V, Valdés S, Laguna A. Cholesterol-lowering effects of policosanol in rabbits. Biol Res 1994; 27: 203.
2. 2. Rodriguez-Echenique C, Mesa R, Más R, Amor A y Castaño G. Estudio del efecto sobre lípidos y lipoproteinas séricas y de la tolerancia al tratamiento oral con dosis crecientes de policosanol en monos Macaca arctoides. Arch Venez Farmacol Terap 1992; 11: 74.
3. 3. Hernández F, Illnait J, Más R, Castaño G, Fernández L, González M, Cordovi N, Fernández J. Effect of Ateromixol (policosanol) on serum lipids and lipoproteins in healthy volunteers. Curr Ther Res 1992; 51: 568.
4. 4. Pons P, Más R, Illnait J, Fernández L, Rodríguez M, Robaina C, Fernández J. Efficacy and safety of policosanol in patients with primary hypercholesterolemia. Curr Ther Res 1992; 52: 507.
5. 5. Pons P, Jiménez A, Rodríguez M, Illnait J, Más R, Fernández L, Fernández J. Effects of policosanol in elderly hypercholesterolemic patients. Curr Ther Res 1993; 53: 265.
6. 6. Pons P, Rodríguez M, Robaina C, Illnait J, Más R, Fernández L, Fernández JC. Effects of policosanol succesive dose increases on lipid profile of patients with type II hypercholesterolemia and tolerability to treatment. Int J Clin Pharmacol Res XIV 1994: 27.
7. 7. Aneiros E, Más R, Calderón B, Illnait J, Fernández L. Effects of policosanol in lowering-cholesterol levels in patients with type II hypercholesterolemia. Curr Ther Res 1995; 56: 176.
8. 8. Castaño G, Zardoya R, Illnait J, Más R, Fernández L, Surribas E, Nodarse M, Fernández J. Efectos del tratamiento con Ateromixol (PPG) (5 mg) en pacientes con hiperlipoproteinemia tipo II. PCM 1991; 5: 21.
9. 9. Canetti M, Moreira M, Illnait J, Más R, Fernández L, Castaño G. One year study on the effect of policosanol (5 mg twice a day) on lipid profile in patients with type II hypercholesterolemia. Adv Ther 1995; 12: 245.
10. 10. Torres O, Agramonte AJ, Illnait J, Más R, Fernández L, Fernández JC. Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care 1995; 18: 393.
11. 11. Arruzazabala ML, Carbajal D, Mas R, Garcia M, Fraga V. Effects of policosanol on platelet aggregation in rats. Thromb Res 1993; 69: 321.
12. 12. Arruzazabala ML, Molina V, Carbajal D, Valdés S, Más R. Effect of policosanol on cerebral ischemia in Mongolian gerbils: Role of prostacyclin and Thromboxane A2. Prostaglandins Leukotrienes Essential Fatty Acids 1993a; 49: 695.
13. 13. Arruzazabala ML, Carbajal D, Molina V, Valdés S, Más R, García M. Estudio farmacologico de la interaccion entre el policosanol y la aspirina en animales de experimentación. Rev Iberoamer Tromb Hemost 1992; 5: 17.
14. 14. Carbajal D, Arruzazabala ML, Molina V, Mas R. Effect of policosanol on experimental thrombosis models. Prostaglandins Leukotrienes Essential Fatty Acids 1994; 50: 249.
15. 15. Arruzazabala ML, Valdés S, Mas R, Fernández L, Carbajal D. Effect of policosanol succesive dose increases on platelet aggregation in healthy volunteers. Pharmacol Res 1996; 33: 131.
16. 16. O'Reilly RA. Anticoagulant, antithrombotic and thrombolytic-drugs. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, eds. The pharmacological basis of therapeutics, 7th ed. New York: Mac-millan, 1990; p. 1338.
17. 17. Dejana E, Villa S, Gaetano G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982; 48: 108.
18. 18. Reyers I, Mysliewiec M, Mussoni L, Donati MB. Stasis-induced venous thrombosis. In: Breddin K, Zimmerman R, eds. Standardization of animal models of thrombosis. Stuttgard: Schattauer, 1983; p. 99.